Claire Gallois

8PUBLICATIONS
55CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 26, 2026
Dual VEGF and PD-(L)1 Blockade: Facts and Hopes.

|Jan 31, 2025
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials.

Claire Gallois, Marine Sroussi, Thierry André

|Apr 02, 2024
Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.

Sophie Mouillet-Richard, Antoine Cazelles, Marine Sroussi

|Mar 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.

Claire Gallois, Qian Shi, Levi D Pederson

|Jul 13, 2023
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors.

Claire Gallois, Matteo Landi, Julien Taieb

|Oct 28, 2022
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.

Claire Gallois, Qian Shi, Jeffrey P Meyers

Pageof 2

Frequent Collaborators

8 joint publications

Julien Taieb

4 joint publications

Pierre Laurent-Puig

3 joint publications

Marine Sroussi

3 joint publications

Sophie Mouillet-Richard